Aqneursa Granule, For Suspension
Product Images NDC 83853-101

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aqneursa (NDC 83853-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Intrabio Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Carton Label)

AQNEURSA 1000 mg granules for oral suspension, 1 gram per sachet, packaged as 28 single-dose sachets. The carton is primarily white with blue and orange text, labeled with levacetylleucine as the active ingredient. Manufactured by IntraBio Inc, the package includes dosing instructions and storage information, showing a placeholder for a barcode and details about product origin from Austria.*

FDA Label Image

Figure Section 11 (Figure Section 11)

Chemical structure of levacetylleucine, the active ingredient in AQNEURSA. The diagram shows the molecular configuration with labeled atoms and bonds, illustrating the arrangement of the compound's functional groups.*

FDA Label Image

Table 4 Section 14 (Table 4 Section 14)

Data table titled 'Summary of mSARA and SARA Efficacy Results' presenting statistical outcomes for Modified Scale for the Assessment and Rating of Ataxia (mSARA) and Scale for the Assessment and Rating of Ataxia (SARA). It includes baseline values, treatment effects compared to placebo, total change versus baseline, and placebo total change, with associated mean differences, estimates, 95% confidence intervals, and p-values.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.